[synthesis.]Internal

Regulatory intelligence — not medical or legal advice.

Appearance
Active: dark
Accent
Corner radius
Font
Layout
Data refresh

Runs once per app session in the background and keeps existing data if source APIs are unavailable.

Annotation style
Ask · OpenAI

Requires OPENAI_API_KEY on the server. Heuristics always run first.

← Disease database

medullary thyroid gland carcinoma

A neuroendocrine carcinoma arising from the C-cells of the thyroid gland. It is closely associated with multiple endocrine neoplasia syndromes. Approximately 10% to 20% of medullary thyroid carcinomas are familial. Patients usually present with a thyroid nodule that is painless and firm. In the majority of cases nodal involvement is present at diagnosis. Surgery is the preferred treatment for both primary lesions and recurrences.

Therapeutic area
Oncology · Endocrine / Metabolic
Rarity
Unknown
Prevalence
MONDO
MONDO:0015277

Overview

A neuroendocrine carcinoma arising from the C-cells of the thyroid gland. It is closely associated with multiple endocrine neoplasia syndromes. Approximately 10% to 20% of medullary thyroid carcinomas are familial. Patients usually present with a thyroid nodule that is painless and firm. In the majority of cases nodal involvement is present at diagnosis. Surgery is the preferred treatment for both primary lesions and recurrences.

This carcinoma is generally not very sensitive to radiation and almost unresponsive to chemotherapy.

Content last reviewed: 2026-06